Search This Blog

Friday, February 25, 2022

Neurocrine upped to Buy from Neutral by Goldman

 Target $115

https://finviz.com/quote.ashx?t=NBIX

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.